Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction

Circulation

Volumn 85, Issue 2, 1992, Pages 659-665

  Thornton, Jon D ^a   Liu, Guang S ^a   Olsson, Ray A ^b   Downey, James M ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Adenosine; Infarcts

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLORO N(6)CYCLOPENTYLADENOSINE; 2-CHLORO-N(6)CYCLOPENTYLADENOSINE; ADENOSINE; DRUG DERIVATIVE; PHENETHYLAMINE DERIVATIVE; PHENYLISOPROPYLADENOSINE; 2 CHLORO 6 N CYCLOPENTYLADENOSINE; ADENOSINE DERIVATIVE;

ANIMAL; ARTICLE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; FEMALE; HEART; HEART INFARCTION; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; MALE; RABBIT; ANIMAL EXPERIMENT; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE; ANIMAL; COMPARATIVE STUDY; CORONARY DISEASE; FEMALE; HEART; HEMODYNAMICS; INJECTIONS, INTRAVENOUS; MALE; MYOCARDIAL INFARCTION; PHENETHYLAMINES; PHENYLISOPROPYLADENOSINE; RABBITS; SUPPORT, NON-U.S. GOV'T;

EID: 0026610144     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.85.2.659     Document Type: Article

References (34)

1. Muny CE, Jennings RB, Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136
2. Uemura N, Knight DR, Shen YT, Nejima J, Cohen MV, Thomas JX Jr, Vatner SF: Increased myocardial infarct size because of reduced coronary collateral blood flow in beagles. Am J Physiol 1989;257:H1798-H1803
3. Li G, Vasquez J, Gallagher K, Lucchesi B: Myocardial protection with preconditioning. Circulation 1990;82:609-619
4. Schott RJ, Rohmann S, Braun ER, Schaper W: Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990;66:1133-1142
5. Iwamoto T, Miura T, Tsuchida A, Ogawa T, Shizukuda Y II, Iimura O: Preconditioning limits infarct size in xanthine oxidase deficient species: It is unlikely to be mediated by free radicals (abstract). Circulation 1989;80(suppl II):II-295
6. Thornton J, Striplin S, Liu G, Swafford A, Stanley A, Van-Winkle DM, Downey JM: Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. Am J Physiol 1990;259:H1822-H1825
7. Thornton J, Van Winkle D, Downey J: Preconditioning protection is mediated through adenosine receptors (abstract). Circulation 1990;82(suppl III):III-44
8. 1 adenosine receptors in the rabbit heart. Circulation 1991;84:350-356
9. Romano FD, MacDonald SG, Dobson JG: Adenosine receptor coupling to adenylate cyclase of rat ventricular myocyte membranes. Am J Physiol 1989;257:H1088-H1095
10. Belardinelli L, Linden J, Berne R: The cardiac effects of adenosine. Prog Cardiovasc Dis 1989;32:73-97
11. Cronstein BN, Kramer SB, Weissman G, Hirschorn R: Adenosine: A physiological modulator of Superoxide anion generation by human neutrophils. J Exp Med 1983;158:1160-1177
12. 2 receptor on human neutrophils. J Immunol 1985;135:1366-1371
13. 2 receptor ligands. J Med Chem 1990;33:1919-1924
14. 6-cyclohexyl [3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine. Proc Natl Acad Sci USA 1980; 77:5547-5551
15. 2 receptors in rat brain. J Pharmacol Exp Ther 1989;251:888-893
16. 1 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 1988;337:687-689
17. Klein HH, Puschmann S, Schaper J, Schaper W: The mechanism of the tetrazolium reaction in identifying myocardial infarction. Virchows Arch [A] 1981;393:287-297
18. Horneffer PJ, Healy B, Gott VL, Gardner TJ: The rapid evolution of a myocardial infarction in an end-artery coronary preparation. Circulation 1987;76(suppl V):V-39-V-42
19. Fishbein MC, Meerbaum S, Rit J, Londo U, Konmatsuse K, Mercier JC, Corday E, Garry W: Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride staining technique. Am Heart J 1981;101: 593-600
20. Schaper W: Experimental infarcts and the microcirculation, in Hearse DJ, Yellos DM (eds): Therapeutic approaches to myocardial infarct size limitation. New York, Raven Press, 1984, p 79
21. Shirato C, Miura T, Ooiwa H, Toyofuku T, Wilborn WH, Downey JM: Tetrazolium artifactually indicates Superoxide dismutase-induced salvage in reperfused rabbit heart. J Mol Cell Cardiol 1989;21:1187-1193
22. Jennings RB, Reimer KA: Effects of beta blockade on acute myocardial injury, in Gross F (ed): Modulation of Sympathetic Tone. Berne, Hans Huber, 1979, p 103
23. Kudoh Y, Maxwell MP, Hearse DJ, Downey JM, Yellon DM: Failure of metoprolol to limit infarct size during 24 hours of coronary occlusion in the closed chest dog. J Cardiovasc Phamacol 1984;6:1201-1209
24. Lang R, Nieminen MS, Kloner RA: Failure of pindolol and metoprolol to reduce size of non-reperfused infarcts in dogs using area at risk techniques. Cardiovasc Res 1984;18:37-43
25. Genth K, Hofmann M, Hofmann M, Schaper W: The effect of beta adrenergic blockade on infarct size following experimental coronary occlusion. Basic Res Cardiol 1981;76:144-151
26. Miura T, Yoshida S II, Iimura O, Downey JM: Dobutamine modifies myocardial infarct size through supply-demand balance. Am J Physiol 1988;254:H855-H861
27. 1 receptors by G proteins in rat ventricular myocytes. Am J Physiol 1990;259:H820-H826
28. Pieper GM, Gross GJ: Protective effect of nicorandil on postischemic function and tissue adenine nucleotides following a brief period of low-flow global ischemia in the isolated rat heart. Pharmacology 1989;38:205-213
29. Grover GJ, McCullough JR, Henry DE, Conder ML, Selph PG: Anti-ischemic effects of the potassium channel activators pinacidil and chromakalim and the reversal of these effects with the potassium channel blocker glyburide. J Pharmacol Exp Ther 1989;251:98-104
30. Auchampach JA, Gross GJ: Myocardial preconditioning is mediated by activation of the ATP regulated potassium channel (abstract). FASEB J 1991;5:A1103
31. Babbitt D, Virmani R, Forman M: Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model (abstract). Circulation 1989;80:1388
32. Norton ED, Jackson EK, Virmani R, Forman MB: Intravenous adenosine limits myocardial reperfusion injury in a model with low myocardial collateral blood flow (abstract). Circulation 1989;80(suppl II):II-238
33. Forman M, Virmani R, Puett D: Mechanisms and therapy of myocardial reperfusion injury (abstract). Circulation 1990; 81(suppl IV):IV-69
34. Schrier DJ, Lesen ME, Wright CD, Gilbertsen RB: The antiinflammatory effects of adenosine receptor agonists on the carrageenan-induced pleural inflammatory response in rats. J Immunol 1990;145:1874-1879